Navigation Links
Astrocyte signaling sheds light on stroke research
Date:3/18/2013

BOSTON (March 18, 2013) New research published in The Journal of Neuroscience suggests that modifying signals sent by astrocytes, our star-shaped brain cells, may help to limit the spread of damage after an ischemic brain stroke. The study in mice, by neuroscientists at Tufts University School of Medicine, determined that astrocytes play a critical role in the spread of damage following stroke.

The National Heart Foundation reports that ischemic strokes account for 87% of strokes in the United States. Ischemic strokes are caused by a blood clot that forms and travels to the brain, preventing the flow of blood and oxygen.

Even when blood and oxygen flow is restored, however, neurotransmitter processes in the brain continue to overcompensate for the lack of oxygen, causing brain cells to be damaged. The damage to brain cells often leads to health complications including visual impairment, memory loss, clumsiness, moodiness, and partial or total paralysis.

Research and drug trials have focused primarily on therapies affecting neurons to limit brain cell damage. Phil Haydon's group at Tufts University School of Medicine have focused on astrocytes, a lesser known type of brain cell, as an alternative path to understanding and treating diseases affecting brain cells.

In animal models, his research team has shown that astrocyteswhich outnumber neurons by ten to onesend signals to neurons that can spread the damage caused by strokes. The current study determines that decreasing astrocyte signals limits damage caused by stroke by regulating the neurotransmitter pathways after an ischemic stroke.

The research team compared two sets of mice: a control group with normal astrocyte signaling levels and a group whose signaling was weakened enough to be made protective rather than destructive. To assess the effect of astrocyte protection after ischemic strokes, motor skills, involving tasks such as walking and picking u
'/>"/>

Contact: Siobhan E. Gallagher
siobhan.gallagher@tufts.edu
617-636-6586
Tufts University, Health Sciences Campus
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Kentucky team inhibits Alzheimers biomarkers in animal model by targeting astrocytes
2. Astrocytes identified as target for new depression therapy
3. Inhibiting Hedgehog signaling pathway may improve pancreatic cancer treatment
4. Grb2 holds powerful molecular signaling pathway in check
5. Aurka-to-p53 signaling: A link between stem cell regulation and cancer
6. Scientist receives $2.8 Million to study cell signaling mechanism and develop potential therapeutics
7. Investigational agent targets gene signaling pathways to improve response for patients with CLL
8. Signaling molecule may help stem cells focus on making bone despite age, disease
9. Study sheds new light on role of genetic mutations in colon cancer development
10. Bonobo Genome Sheds Light on Their Links to Chimps, Humans
11. Genetic Research Sheds Light on Jewish Diaspora
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Wailea, Maui, HI (PRWEB) July 29, 2014 ... Four Seasons Resort Maui at Wailea. This September through ... many of them free-- tailored to couples of all ages ... great and guests can take advantage of the Resort's popular ... to $1,000 while the "twice yearly sale" is in full ...
(Date:7/29/2014)... Tucson-based company Outski has created a ... and wellness program, called 401(play)™. A 401(play)™ plan promotes ... for employees to use their earned vacation time. In ... the amount of each paycheck to be put into ... offering a 401(play)™ plan to in several ways; for ...
(Date:7/29/2014)... In today’s world, a good night’s sleep has become especially ... (a medical problem where the airway collapses during sleep and ... rest they need to face their daily challenges. , ... people in the United States alone have sleep apnea. Of ... those treated, many cannot tolerate their prescribed medical device known ...
(Date:7/29/2014)... Dallas, Texas (PRWEB) July 29, 2014 Guests ... , will be indulged in a new sleep experience. The ... INTENTIONS™ Linens by Peacock Alley. , These expertly crafted, ... simple striped pattern from a distance, yet upon closer look, ... gentle reminders to relax, sleep and breathe. , ...
(Date:7/29/2014)... The Multiple System Atrophy Coalition, a growing nonprofit ... five new members to its Board of Directors. ... its executive directors. The MSA Coalition now has ... Advisors. These 12 dedicated volunteers are fully focused ... advocacy and research funding for the neurological disorder Multiple ...
Breaking Medicine News(10 mins):Health News:Four Seasons Resort Maui at Wailea Goes All Out to Give Couples Memorable Get-Away this Fall at Maui’s Luxury Resort 2Health News:Four Seasons Resort Maui at Wailea Goes All Out to Give Couples Memorable Get-Away this Fall at Maui’s Luxury Resort 3Health News:Outski launches 401(play)™ Plan to Employers as Part of an Employee Benefit / Health and Wellness Program 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Auberge Du Soleil Offers INTENTIONS™ by Peacock Alley on Guests' Beds Providing a Unique Sleep Experience 2Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 2Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 3Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 4
... Wound Care,Innovations, LLC, a subsidiary of Wound ... the 510k clearance of a new wound,management product ... new addition to our product line (patent pending) ... (PSGAG) and will initially be available in gel ...
... Cord Blood,America, Inc. (OTC Bulletin Board: CBAI), the ... ) focused on,bringing the life saving potential of ... that a letter to shareholders from CEO Matthew,Schissler ... letter explains,some of the positive scientific and economic ...
... Corgenix Medical Corporation,(OTC Bulletin Board: CONX), a ... sales of $2,001,896 for the first fiscal,quarter ended ... quarter,ended September 30, 2007, a decrease of 4.9%. ... over the same period,in the prior fiscal year., ...
... China, Nov. 13 /Xinhua-PRNewswire-FirstCall/ -- China,Information Security ... Information,Security," "CIST" or the "Company"), a leading ... Information,Systems ("GIS") solutions provider to public security ... for 2009., China Information Technology has ...
... people choose to get representation when they apply for SSDI, a ... ... Belleville, IL (Vocus) November 13, 2008 -– Difficult decisions ... and one of the most important is how to begin the ...
... Nov. 13 TheraQuest Biosciences, Inc. a,development ... the U.S.,Food and Drug Administration (FDA) has ... TQ-1015, its abuse deterrent extended release,strong opioid. ... abuse deterrent technology., Najib Babul, PharmD, ...
Cached Medicine News:Health News:Wound Management Technologies, Inc. Announces FDA Clearance of 510k 2Health News:Wound Management Technologies, Inc. Announces FDA Clearance of 510k 3Health News:Cord Blood America Posts Letter to Shareholders: New Administration's Potential Enhanced Stem Cell Research Initiative Should Benefit the Company and Its Shareholders 2Health News:Cord Blood America Posts Letter to Shareholders: New Administration's Potential Enhanced Stem Cell Research Initiative Should Benefit the Company and Its Shareholders 3Health News:Corgenix Reports Financial Results for First Quarter of Fiscal 2009 2Health News:Corgenix Reports Financial Results for First Quarter of Fiscal 2009 3Health News:China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009 2Health News:China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009 3Health News:China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009 4Health News:China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009 5Health News:Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 2Health News:Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 3Health News:Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 4Health News:Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 5Health News:Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 6Health News:TheraQuest's IND for Abuse Deterrent Strong Opioid (TQ-1015) Accepted by FDA 2
(Date:7/29/2014)... --   Glide Pharmaceutical Technologies ... an exclusive worldwide licence to an innovative prostate cancer ... University spin-out company.  Under the terms of ... development and commercial milestone payments, and royalties on future ... for additional exclusive licences to FScan diagnostic technologies, for ...
(Date:7/29/2014)... --   , First patient begins ... and safety of MSB0010718C in patients with metastatic Merkel cell ... skin cancer lacking effective treatments   MSB0010718C is also ... trial for the treatment of solid tumors that aims to ... subsidiary of Merck KGaA, Darmstadt, Germany , ...
(Date:7/28/2014)... -- Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ) ... audio webcast to discuss financial results for the second quarter ... 31, 2014 at 4:30 p.m. ET. Conference ... 31, 2014 Time: 4:30 PM ET Listen via Internet: ... A webcast replay will be available on the Pharmacyclics ...
Breaking Medicine Technology:Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer 2Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 2EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 4EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 5Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014 2
... Prostate Conditions Education Council (PCEC) – a ... in prostate cancer screening – today announced it strongly ... Services Task Force (USPSTF). The draft guidance recommends against ... PCEC believes that until a more accurate and ...
... 10, 2011 PDI, Inc. (Nasdaq: ... R. Melillo, Jr. as senior vice president of Business ... drive PDI,s commercial outsource services and contract sales business. ... officer. Melillo was most recently general manager ...
Cached Medicine Technology:Prostate Conditions Education Council Opposes U.S. Preventative Services Task Force Recommendation 2Prostate Conditions Education Council Opposes U.S. Preventative Services Task Force Recommendation 3PDI Appoints Gerald R. Melillo, Jr. As SVP of Business Development 2
... rub formula is the most convenient multi-purpose ... in one bottle without the need to ... contact lenses and removes protein build-up when ... that contains Hydranate, a special ingredient that ...
Grafton Trial Frame...
The award-winning new Universal Trial Frame (UB4), the ergonomic refraction design from Oculus that's easier to use, easier to wear....
Half Eye Trial Frame - Adult...
Medicine Products: